Episode 159: Semaglutide with Megan Del Corral
Today Megan Del Corral from Advanced Vitality HRT joined us to discuss the low down on Semaglutide, the newest incretin mimetic to hit the market to target insulin and weight loss resistance. We dive deep into the cellular mechanisms of GLP-1RAs as they related to hunger signaling, fat loss, and special population who should or shouldn't use incretin mimetics.
For more information on consulting with Advanced Vitality HRT, please visit: advancedvitalityhrt.com
www.theexcellencecartel.com
